Literature DB >> 17447224

Firocoxib efficacy preventing urate-induced synovitis, pain, and inflammation in dogs.

Marlene Drag1, Bruce N Kunkle, Davida Romano, Peter D Hanson.   

Abstract

This positive-control study evaluated the efficacy of firocoxib versus carprofen, deracoxib, and meloxicam for the prevention of pain and inflammation in a urate crystal synovitis model of lameness. Lameness scoring and force plate gait analysis were used to assess efficacy. The resulting lameness scores and force plate ground reaction forces after urate crystal injection were not significantly different among the groups. Relative to each group's baseline (nonlame) score, only the firocoxib group was not significantly lame, based on lameness score, at the model's peak effect.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17447224

Source DB:  PubMed          Journal:  Vet Ther        ISSN: 1528-3593


  4 in total

Review 1.  Analgesia for Sheep in Commercial Production: Where to Next?

Authors:  Alison Small; Andrew David Fisher; Caroline Lee; Ian Colditz
Journal:  Animals (Basel)       Date:  2021-04-14       Impact factor: 2.752

2.  Pharmacokinetic/pharmacodynamic modeling for the determination of a cimicoxib dosing regimen in the dog.

Authors:  Elisabeth C Jeunesse; Marc Schneider; Frederique Woehrle; Mathieu Faucher; Herve P Lefebvre; Pierre-Louis Toutain
Journal:  BMC Vet Res       Date:  2013-12-11       Impact factor: 2.741

3.  Assessment of the efficacy of firocoxib (Previcox®) and grapiprant (Galliprant®) in an induced model of acute arthritis in dogs.

Authors:  Andrea García de Salazar Alcalá; Lucile Gioda; Alia Dehman; Frederic Beugnet
Journal:  BMC Vet Res       Date:  2019-08-29       Impact factor: 2.741

4.  Effect of analgesic therapy on clinical outcome measures in a randomized controlled trial using client-owned dogs with hip osteoarthritis.

Authors:  Sarah Malek; Susannah J Sample; Zeev Schwartz; Brett Nemke; Peer B Jacobson; Elizabeth M Cozzi; Susan L Schaefer; Jason A Bleedorn; Gerianne Holzman; Peter Muir
Journal:  BMC Vet Res       Date:  2012-10-04       Impact factor: 2.741

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.